Rini BI - Search Results

1

A phase I trial of fixed dose rate gemcitabine and capecitabine in metastatic renal cell carcinoma.

Rini BI, Weinberg V, Small EJ. Rini BI, et al. Cancer. 2005 Feb 1;103(3):553-8. doi: 10.1002/cncr.20795. Cancer. 2005. PMID: 15612026 Free article. Clinical Trial.

2

Granulocyte-macrophage--colony stimulating factor in metastatic renal cell carcinoma: a phase II trial.

Rini BI, Stadler WM, Spielberger RT, Ratain MJ, Vogelzang NJ. Rini BI, et al. Cancer. 1998 Apr 1;82(7):1352-8. doi: 10.1002/(sici)1097-0142(19980401)82:7<1352::aid-cncr19>3.0.co;2-5. Cancer. 1998. PMID: 9529028 Clinical Trial.

3

Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil in patients with metastatic renal cell cancer.

Rini BI, Vogelzang NJ, Dumas MC, Wade JL 3rd, Taber DA, Stadler WM. Rini BI, et al. J Clin Oncol. 2000 Jun;18(12):2419-26. doi: 10.1200/JCO.2000.18.12.2419. J Clin Oncol. 2000. PMID: 10856102 Clinical Trial.

4

Allogeneic peripheral blood stem cell transplantation for metastatic renal cell carcinoma.

Rini BI, Zimmerman TM, Gajewski TF, Stadler WM, Vogelzang NJ. Rini BI, et al. J Urol. 2001 Apr;165(4):1208-9. J Urol. 2001. PMID: 11257677 No abstract available.

5

An update on prostate cancer.

Rini BI, Small EJ. Rini BI, et al. Curr Opin Oncol. 2001 May;13(3):204-11. doi: 10.1097/00001622-200105000-00013. Curr Opin Oncol. 2001. PMID: 11307066 Review.

6

Immunotherapy for prostate cancer.

Rini BI, Small EJ. Rini BI, et al. Curr Oncol Rep. 2001 Sep;3(5):418-23. doi: 10.1007/s11912-001-0028-1. Curr Oncol Rep. 2001. PMID: 11489243 Review.

7

A phase II trial of weekly intravenous gemcitabine and cisplatin with continuous infusion fluorouracil in patients with metastatic renal cell carcinoma.

George CM, Vogelzang NJ, Rini BI, Geoffroy FJ, Kollipara P, Stadler WM. George CM, et al. Among authors: rini bi. Ann Oncol. 2002 Jan;13(1):116-20. doi: 10.1093/annonc/mdf008. Ann Oncol. 2002. PMID: 11863091 Free article. Clinical Trial.

8

Allogeneic stem-cell transplantation of renal cell cancer after nonmyeloablative chemotherapy: feasibility, engraftment, and clinical results.

Rini BI, Zimmerman T, Stadler WM, Gajewski TF, Vogelzang NJ. Rini BI, et al. J Clin Oncol. 2002 Apr 15;20(8):2017-24. doi: 10.1200/JCO.2002.08.068. J Clin Oncol. 2002. PMID: 11956260 Clinical Trial.

9

Prostate cancer update.

Rini BI, Small EJ. Rini BI, et al. Curr Opin Oncol. 2002 May;14(3):286-91. doi: 10.1097/00001622-200205000-00006. Curr Opin Oncol. 2002. PMID: 11981273 Review.

10

Flt-3 ligand and sequential FL/interleukin-2 in patients with metastatic renal carcinoma: clinical and biologic activity.

Rini BI, Paintal A, Vogelzang NJ, Gajewski TF, Stadler WM. Rini BI, et al. J Immunother. 2002 May-Jun;25(3):269-77. doi: 10.1097/00002371-200205000-00010. J Immunother. 2002. PMID: 12000869 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

523 results

Search Page

Filters